Nevisense for Skin Barrier Assessment
Research/Cosmetic Testing; Inflammatory Skin Disease Monitoring
Commercial/DevelopmentCE Mark for measurement
Key Facts
Indication
Research/Cosmetic Testing; Inflammatory Skin Disease Monitoring
Phase
Commercial/Development
Status
CE Mark for measurement
Company
About Scibase
SciBase's mission is to pioneer prediction and prevention in skin health by empowering clinicians with advanced diagnostic tools. Its key achievement is the development and commercialization of the Nevisense platform, which has gained regulatory approval for melanoma and keratinocyte cancer detection based on robust clinical evidence. The company's strategy focuses on expanding the platform's applications, scaling commercial operations in key markets, and leveraging its unique EIS+AI technology to become a standard of care in dermatological diagnostics.
View full company profile